QUINTA-ANALYTICA, as part of Conscio Group, along with our network of companies, is looking forward to reconnecting with our current partners and friends, as well as establishing new collaborations at the pharmaceutical event of the year.

Visit us at the Conscio Group booth 22G4 in the Integrated Pharma Hall to explore how our combined expertise can drive drug development in innovative formulations, pharmaceutical research, analytical solutions for pharmaceuticals and biologics, and clinical development, including trials and bioanalysis.

You’ll also have the opportunity to meet our strategic partner, Kiel Laboratories, based in USA, who specializes in supporting pharmaceutical companies in bringing new drugs to market, particularly through the 505(b)(2) process of the US-FDA approval.

If you’re interested in arranging a meeting with us, please reach out to your business representative or send an email to sales@quinta.cz, and we will schedule a time slot for you.

Additional News

  • 9 July 2025

    HER-096: A possible breakthrough in Parkinson’s disease treatment

    This testimonial highlights our collaboration with Herantis Pharma on the analytical development and nonclinical support for HER-096, a promising candidate in the fight against Parkinson’s disease.

  • 9 June 2025

    Ensuring Success in Buccal Film Development: The Midazolam Film Case Study

    Fast, Simple, Effective: Unlocking the Potential of Midazolam Films

  • 15 May 2025

    From Analytical Similarity to Clinical Data: Tailoring Evidence for Biosimilar Approval

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar.